Cecilia Jiménez Mallebrera
Jefe de Grupo Senior
Research group
Researcher Cecilia Jiménez graduated in Biology from the University of Navarra and from the University of Buckingham in 1996 and earned her PhD in Genetics from the University of London (UCL) in 2001. In 2005, she obtained the degree of Clinical Scientist for the Health and Care Professions Council of the United Kingdom.
Between 2001 and 2010, she undertook a postdoctoral stay at the Dubowitz Neuromuscular Center (now in Great Ormond Street Hospital, London) and the Dept. Of Neuropathology at the Charing Cross Hospital, London where she specialized in neuromuscular pathologies and in the genetics and mechanisms of congenital muscular dystrophies.
She is a member of the European networks EURO-NMD and Treat-NMD and CIBERER.
In 2010, she joined as Researcher Miguel-Servet and group leader at the FSJD.
She is currently leading the group of applied research in neuromuscular diseases whose main objectives are to deepen the mechanism by which neuromuscular diseases occur, to improve the diagnosis of patients by identifying new biomarkers and methodologies and to investigate advanced therapies based, among others, on the genetic edition.
Professional network profiles
Related websites
SJD Barcelona Children's Hospital Last Publications
- White, Tom, López-Marquez A, Badosa, Carmen, Jimenez-Mallebrera C, Samitier, Josep, Giannotti, Marina Ines and Lagunas, Anna Nanomechanics of cell-derived matrices as a functional read-out in collagen VI-related congenital muscular dystrophies JOURNAL OF THE ROYAL SOCIETY INTERFACE . 22(224): .
- Cavazza A, Molina-Estévez FJ, Plaza-Reyes A, Ronco V, Naseem A, Malensek S, Pecan P, Santini A, Heredia P, Aguilar-González A, Boulaiz H, NI Q, Cortijo-Gutierrez M, Pavlovic K, Herrera I, de la Cerda B, García-Tenorio EM, Richard E, Granados-Principal S, López-Marquez A, Kober M, Stojanovic M, Vidakovic M, Santos-Garcia I, Blazquez L, Haugthon E, Yan D, Sanchez-Martin RM, Mazini L, Gonzalez-Aseguinolaza G, Miccio A, Rio P, Desviat LR, Gonçalves M, Peng L, Jimenez-Mallebrera C, Martin-Molina F, Gupta D, Lainscek D, Luo Y and Benabdellah K Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group MOLECULAR THERAPY NUCLEIC ACIDS . 36(1): 102457.
- Justel M, Jou-Munoz C, Sariego-Jamardo A, Julià-Palacios NA, Ortez-Gonzalez CI, Poch ML, Hedrera-Fernandez A, Gomez-Martin H, Codina-Bergadà A, Domínguez-Carral J, Muchart-Lopez J, Hernández-Laín A, Vila-Bedmar S, Zulaica M, Cancho-Candela R, Castro MDC, de la Osa-Langreo A, Peña-Valenceja A, Marcos-Vadillo E, Prieto-Matos P, Pascual-Pascual SI, López de Munain A, Camacho A, Estévez-Arias B, Musokhranova U, Olivella M, De Oyarzabal-Sanz AL, Jimenez-Mallebrera C, Domínguez-González C, Nascimento-Osorio A, Garcia-Cazorla A and Natera-de Benito D Expanding the phenotypic spectrum of TRAPPC11-related muscular dystrophy: 25 Roma individuals carrying a founder variant JOURNAL OF MEDICAL GENETICS . 60(10): 965-973.
Projects
- Project name:
- ERDERA_EUROPEAN RARE DISEASES RESEARCH ALLIANCE
- Leader
- Cecilia Jiménez Mallebrera
- Funding entities:
- European Commission
- Code
- 101156595
- Starting - finishing date:
- 2024 - 2031
- Project name:
- CMG2 receptor: Deciphering its role in the pathophysiology of COL6-RDs and its potential as a therapeutic target
- Leader
- Arístides Lopez Marquez
- Funding entities:
- Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD, Association Francaise Contre les Myophaties, Lopez Marquez, Arístides
- Code
- 28815
- Starting - finishing date:
- 2024 - 2026
- Project name:
- MyoQ: La plataforma de Nanomedicina para terapias avanzadas contra las Distrofias Musculares Congénitas
- Leader
- Cecilia Jiménez Mallebrera
- Funding entities:
- Federación Española de Enfermedades Raras
- Code
- AI-2023-045
- Starting - finishing date:
- 2024 - 2025
News
-
Discussing photonics tools for pediatrics in the 3rd BMPN annual meeting
The Barcelona Medical Photonics Network celebrated the third edition of its annual meeting, gathering experts focuses discussion on photonic techniques to improve diagnostics and treatment personalization in pediatrics.
-
Nanomedicine to tackle rare diseases
Experts in nanomedicine from various fields have gathered today for the fifth consecutive year at Nano Rare Diseases Day. This event is co-organized by IRSJD and the NANOMED Spain platform, coordinated by IBEC.
-
Characterization of Extracellular Vesicles in Fibroblasts of Collagen-VI Related Muscular Dystrophy
A team led by the Applied research in neuromuscular diseases at the Institut de Recerca Sant Joan de Déu · SJD Barcelona Children's Hospital has made significant advancements in comprehending the pathogenesis of Collagen-VI Related Muscular Dystrophy (COL6-RD) by analyzing extracellular vesicles and their correlation with cellular mobility.